Delivery Order SPE2DB22D2211-SPE2DB25FRYDN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,035.56 to AmerisourceBergen Drug Corp for Veltassa 16.8 GM powder packets (30-count) on September 24, 2025, with completion expected by September 25, 2025. This non-set-aside, firm fixed-price delivery order represents a pharmaceutical supply requirement fulfilled through the company's existing contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,987.14 to AmerisourceBergen Drug Corp for the supply of Veltassa 8.4 GM powder packets (30-count packages). This is a firm fixed price, competitively awarded contract with no set-aside designation, with a completion date of September 10, 2025. The award was issued on September 9, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a $1,358.10 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Veltassa 8.4 gm powder packets (30-count units). This is a non-set-aside competitive award with an ultimate completion date of July 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $3,173.79 to AmerisourceBergen Drug Corp for Veltassa 8.4 GM powder packets (30-count). The contract, issued on July 10, 2025, with an ultimate completion date of July 11, 2025, utilizes firm fixed-price pricing under a non-set-aside competitive procurement. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Veltassa 8.4 GM Powder Packet (30-count) with a ceiling value of $1,358.10. This is a firm fixed price delivery order with no set-aside designation, meaning the award was made through open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 29, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $8,863.59 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Veltassa 8.4 GM Powder Packet in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of September 11, 2025, and was awarded competitively without set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $2,565.83 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count units). This is a firm fixed-price contract with an ultimate completion date of August 26, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $4,074.30 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Veltassa 8.4 GM powder packets (30 count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 31, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count) valued at $3,964.51. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for Veltassa 8.4 GM powder packets (30-count) under a firm fixed-price contract valued at $2,469.40, with an ultimate completion date of September 2, 2025. This non-competitive delivery order represents a procurement of pharmaceutical products for military healthcare needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FRYDNDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,358.10 to AmerisourceBergen Drug Corp for the supply of Veltassa 8.4 GM powder packets (30-count) on May 30, 2025, with completion targeted for June 2, 2025. This firm fixed-price delivery order is non-set-aside and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare systems, including the Defense Health Agency and U.S. Coast Guard. Veltassa, a potassium-binding pharmaceutical, represents one of the specialized medications within the company's broader portfolio of brand-name and generic drugs delivered through the DLA Medical Supply Chain to support military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 5/30/25 |